Serotype Distribution, Virulence Determinants and Antimicrobial Susceptibility of Streptococcus agalactiae Isolated

Zhengjiang Jin1, Juan Li2, Haijian Zhou2

  • 1Department of Clinical Laboratory, Maternal and Child Health Hospital of Hubei Province, Wuhan 430070, China.

Insights

This study analyzed genetic characteristics of Streptococcus agalactiae (Group B Streptococcus, GBS) in Chinese infants. Serotype III, ST17, and Rib surface protein were predominant, highlighting genetic variations influencing virulence and antibiotic resistance.

Area of Science:

  • Microbiology
  • Genetics
  • Infectious Diseases

Background:

  • Streptococcus agalactiae (Group B Streptococcus, GBS) causes significant neonatal infections globally.
  • Understanding GBS genetic diversity, including surface proteins and virulence factors, is crucial for managing infections, especially in China where data is limited.

Purpose of the Study:

  • To investigate the genetic characteristics of clinical GBS isolates from infected infants in China.
  • To analyze serotypes, surface proteins, virulence determinants, and antibiotic resistance genes.

Main Methods:

  • Whole-genome sequencing and Multilocus Sequence Typing (MLST) were performed on 97 GBS isolates from infected infants (2017-2021).
  • Analysis included assessment of GBS serotypes, sequence types (STs), clonal complexes (CCs), surface protein genes (e.g., Rib, srr1, hvgA), pilus island genes, and antibiotic resistance genes.

Main Results:

  • Serotype III (49.5%) and ST17 (23.7%) were the most prevalent GBS types.
  • The Rib surface protein was predominant (41.2%), mainly in serotype III strains.
  • Significant proportions of isolates carried antibiotic resistance genes (tetM, tetO/tetL, ermB) and specific virulence gene profiles (cfb-cylE-lmb-pavA), particularly in serotype III/CC17.

Conclusions:

  • Whole-genome sequencing revealed substantial genetic variation in GBS surface proteins, virulence, and antibiotic resistance in Chinese infant isolates.
  • These findings provide critical insights into GBS genetic features and pathogenic dynamics.
  • Continuous epidemiological surveillance is essential for improving GBS treatment outcomes.

Related Concept Videos